European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Healio3m
RSV may elevate risk for stroke, heart failure hospitalization
Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...
European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...
McKnight's Long-Term Care News5d
Older adults more apt to receive RSV vaccine, but uptake low in long-term care: study
Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...
Pharmaceutical Technology on MSN6d
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK
Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
Zacks.com on MSN5d
PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo
The latest decision makes Pfizer's Abrysvo the first RSV vaccine approved for use in non-pregnant adults under 50 years of ...
Pulmonology Advisor6d
Atrial Fibrillation Risk Not Increased After RSV Vaccination in High-Risk Older Adults
The risk for new-onset or recurrent AF was not increased among older adult patients with preexisting conditions following RSV vaccination.
The Pharma Letter6d
TGA approval for Moderna RSV vaccine for older adults
Australian medicines regulator, the Therapeutic Goods Administration (TGA), has granted approval for mRESVIA (mRNA-1345), an ...
CIDRAP4d
RSV vaccine uptake in adults tied to older age, pulmonary disease
The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...
Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods ...
Reuters6d
European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
RSV is a common virus that can be deadly and is most dangerous for the very young and the elderly. U.S. drugmaker Pfizer and the UK's GSK are each banking on strong sales of their RSV shots ...